PATENT CLAIM ANALYSIS

Application Number: 16418754
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["514", "396000"]

Abstract:
The presently disclosed subject matter relates to methods of administering an effective amount of dexmedetomidine to a pediatric patient in order to reduce the incidence of neurological damage. More particularly, the presently disclosed subject matter relates to methods of providing sedation or analgesia to a pediatric patient by administering a dexmedetomidine infusion and optionally a loading dose. The dexmedetomidine can be administered before, during, or after surgery.

Claim (Index 10):
The method of  claim 9 , wherein the pharmaceutical composition comprises dexmedetomidine or a pharmaceutically acceptable salt thereof at a concentration of about 4 \u03bcg/mL.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 100.0
- Lexical Diversity: 1.62222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13726496', '13726479', '13471403', '15702319', '13711407']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8267148631132127
- 35 USC 102 Novelty (BERT): 0.5942086609645678
- Combined Prediction Score: 0.8034642428983483
- Mean Citation Score: 471.87778599999984
- Max Citation Score: 614.15765
- Similarity Product: 413.46514027097817

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test